Related Experiment Video
Updated: Jul 7, 2026

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
Published on: August 16, 2024
Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation
Alessio Coi1, Ilaria Massarelli, Lara Testai
1Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy.
Abstract:
Drugs delaying cardiac repolarization by blockade of hERG K(+) channel generally prolong the QT interval of the electrocardiogram, an effect regarded as a cardiac risk factor with the potential to cause 'torsade des pointes'-type arrhythmias in humans. The present study applied a homology building technique and molecular dynamics simulations to model the pore of hERG K(+) channel. A docking analysis was then performed on selected ligands which were classified as QT-prolonging or non-prolonging after experimental measurements in in vivo anesthetized guinea pig. The results of this structural analysis provided a "toxicophoric" model that was further exploited to inspect a dataset of known QT-prolonging/non-prolonging molecules. The emerging major chemical features to be avoided, in order to obtain cardiac safe therapeutic agents, comprise the simultaneous presence of (i) a protonated nitrogen atom within an observed range of distances from a heteroatom; (ii) aromatic groups capable of interacting within an area defined by Gly657 residues of the pore or within an area located at the top of the longitudinal axis of the pore. Moreover, additional hydrophobic moieties interacting with one of the equatorial cavities located in the area near-by Tyr652 residues and/or with a hydrophobic ring defined by Phe656 residues should be avoided.
Insights
This study models the hERG K+ channel pore to identify chemical features that cause QT prolongation. Avoiding specific protonated nitrogen, aromatic, and hydrophobic groups can help develop safer cardiac drugs.
Area of Science:
- Cardiovascular Pharmacology
- Computational Chemistry
- Drug Safety
Background:
- Drugs blocking the hERG K+ channel can prolong the QT interval, increasing arrhythmia risk.
- Identifying structural features that lead to QT prolongation is crucial for drug development.
Purpose of the Study:
- To develop a "toxicophoric" model of the hERG K+ channel pore.
- To identify key chemical features associated with QT-prolonging drug effects.
Main Methods:
- Homology modeling and molecular dynamics simulations to build the hERG K+ channel pore model.
- Docking analysis of known QT-prolonging and non-prolonging drug candidates.
- Inspection of molecular datasets using the derived "toxicophoric" model.
Main Results:
- A structural model of the hERG K+ channel pore was generated.
- Key chemical features linked to QT prolongation were identified.
- Specific molecular interactions within the pore were correlated with drug safety profiles.
Conclusions:
- The study provides a "toxicophoric" model to guide the design of safer therapeutic agents.
- Avoiding specific protonated nitrogen, aromatic, and hydrophobic moieties is recommended for cardiac safety.
- This model can aid in predicting and mitigating the risk of QT prolongation in new drug candidates.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Drug Toxicity: Risk factors
Drug Toxicity: Dose-Dependent Reactions
Drug toxicity: Idiosyncratic Reactions
Drug toxicity: Drug–Drug Interaction
Drug Toxicity: Overview
